Bio-Techne (TECH) Accumulated Expenses (2010 - 2026)

Bio-Techne has reported Accumulated Expenses for 17 years, with the latest figure at $17.7 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 71.43% year-over-year to $17.7 million; the trailing twelve-month figure through Mar 2026 stood at $17.7 million (down 71.43% YoY), and the FY2025 full-year result was $25.7 million, down 48.49% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $17.7 million, down from $45.0 million in the prior quarter.
• The five-year high for Accumulated Expenses was $62.0 million in Q2 2022, with the low at $13.8 million in Q3 2022.
• Average Accumulated Expenses over 5 years is $36.1 million, with a median of $36.7 million recorded in 2023.
• Year-over-year, Accumulated Expenses jumped 305.4% in 2022 and plunged 71.43% in 2026.
• Tracing TECH's Accumulated Expenses over 5 years: stood at $16.3 million in 2022, then surged by 102.68% to $33.0 million in 2023, then surged by 62.43% to $53.6 million in 2024, then declined by 15.99% to $45.0 million in 2025, then plunged by 60.73% to $17.7 million in 2026.
• The last three Accumulated Expenses figures came in at $17.7 million (Q1 2026), $45.0 million (Q4 2025), and $19.2 million (Q3 2025), per Business Quant data.

Peer Comparison